George Clinical and Omico Align to Evolve Oncology Study Enrollment Through Genomic Profiling in Australia

SYDNEY, June 16 (Bernama-GLOBE NEWSWIRE) — George Clinical, a global scientifically-backed clinical research organization, and Omico, an Australian-based not-for-profit national precision oncology platform, have aligned to revolutionize oncology clinical trial access for patients and improve the efficiency of study enrollment.  The two organizations began collaborating in late 2020 and announced the joint effort during the 2021 ASCO Annual Meeting. 

http://mrem.bernama.com/viewsm.php?idm=40281